Vir Biotechnology (VIR) Current Assets (2018 - 2026)
Vir Biotechnology (VIR) posted Current Assets of $523.0 million for Q1 2026, up 1.73% sequentially from $514.1 million in Q4 2025, and down 43.9% YoY from $932.2 million in Q1 2025.
Vir Biotechnology (VIR) Current Assets (2018 - 2026) Analysis & Trends
Vir Biotechnology has reported Current Assets for 9 years, with the latest figure at $523.0 million in Q1 2026.
- Quarterly Current Assets fell 43.9% year-over-year to $523.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $523.0 million (down 43.9% YoY) and the FY2025 annual result came in at $514.1 million, down 50.69% from the prior year.
- Current Assets rose to $523.0 million in Q1 2026 per VIR's latest filing, from $514.1 million in the prior quarter.
- Over five years, Current Assets peaked at $2.6 billion in Q1 2022 and troughed at $514.1 million in Q4 2025.
- A 5-year average of $1.5 billion and a median of $1.2 billion in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2025: Current Assets surged 165.37% in 2022, then slumped 50.69% in 2025.
- Over 5 years, Current Assets stood at $2.5 billion in 2022, then slumped by 36.95% to $1.6 billion in 2023, then slumped by 34.36% to $1.0 billion in 2024, then plunged by 50.69% to $514.1 million in 2025, then rose by 1.73% to $523.0 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $523.0 million, $514.1 million, and $545.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Vir Biotechnology | 1.56 Bn | 1.56 Bn | 238.95 Mn | 573.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 573.74 Mn |
| Mar 31, 2026 | 522.99 Mn |
| Dec 31, 2025 | 514.08 Mn |
| Sep 30, 2025 | 545.68 Mn |
| Jun 30, 2025 | 735.71 Mn |
| Mar 31, 2025 | 932.21 Mn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.77 Bn |
| Jun 30, 2023 | 1.95 Bn |
| Mar 31, 2023 | 2.36 Bn |
| Dec 31, 2022 | 2.52 Bn |
| Sep 30, 2022 | 2.41 Bn |
| Jun 30, 2022 | 2.29 Bn |
| Mar 31, 2022 | 2.57 Bn |
| Dec 31, 2021 | 1.56 Bn |
| Sep 30, 2021 | 1.07 Bn |